Growth Metrics

OmniAb (OABI) Non-Current Deferred Tax Liability (2021 - 2026)

OmniAb (OABI) reported Non-Current Deferred Tax Liability of $1.2 million for Q1 2026, down 44.43% year-over-year from $2.2 million in Q1 2025, and up 56.31% on a QoQ basis from $785000.0 in Q4 2025.

OmniAb (OABI) has 6 years of Non-Current Deferred Tax Liability data on file, last reported at $1.2 million in Q1 2026.

  • Quarterly Non-Current Deferred Tax Liability fell 44.43% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (down 44.43% YoY) and the FY2025 annual result came in at $785000.0, down 97.78% from the prior year.
  • Non-Current Deferred Tax Liability grew to $1.2 million in Q1 2026 per OABI's latest filing, from $785000.0 in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $35.4 million in Q4 2024 and bottomed at $785000.0 in Q4 2025.
  • The 5-year median for Non-Current Deferred Tax Liability is $7.8 million (2024), against an average of $10.5 million.
  • The widest annual swing landed in 2024, when Non-Current Deferred Tax Liability surged 211.63%; it then tumbled 97.78% in 2025.
  • Tracing OABI's Non-Current Deferred Tax Liability over 5 years: stood at $21.3 million in 2022, then sank by 46.8% to $11.4 million in 2023, then surged by 211.63% to $35.4 million in 2024, then plunged by 97.78% to $785000.0 in 2025, then soared by 56.31% to $1.2 million in 2026.
  • Per Business Quant, the three latest OABI Non-Current Deferred Tax Liability figures stand at $1.2 million (Q1 2026), $785000.0 (Q4 2025), and $1.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 OmniAb 334.72 Mn 291.75 Mn 14.41 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.23 Mn
Mar 31, 2026 1.23 Mn
Dec 31, 2025 785,000.00
Dec 31, 2025 785,000.00
Sep 30, 2025 1.17 Mn
Sep 30, 2025 1.17 Mn
Jun 30, 2025 2.33 Mn
Jun 30, 2025 2.33 Mn
Mar 31, 2025 2.21 Mn
Mar 31, 2025 2.21 Mn
Dec 31, 2024 35.38 Mn
Dec 31, 2024 35.38 Mn
Sep 30, 2024 4.13 Mn
Sep 30, 2024 4.13 Mn
Jun 30, 2024 6.84 Mn
Jun 30, 2024 6.84 Mn
Mar 31, 2024 8.74 Mn
Mar 31, 2024 8.74 Mn
Dec 31, 2023 11.35 Mn
Dec 31, 2023 11.35 Mn
Sep 30, 2023 13.87 Mn
Sep 30, 2023 13.87 Mn
Jun 30, 2023 17.19 Mn
Jun 30, 2023 17.19 Mn
Mar 31, 2023 20.40 Mn
Mar 31, 2023 20.40 Mn
Dec 31, 2022 21.34 Mn
Dec 31, 2022 21.34 Mn
Dec 31, 2021 21.96 Mn
Dec 31, 2021 21.96 Mn